"Chemokine CCL21" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CC-type chemokine with specificity for CCR7 RECEPTORS. It has activity towards DENDRITIC CELLS and T-LYMPHOCYTES.
| Descriptor ID |
D054421
|
| MeSH Number(s) |
D12.644.276.374.200.110.890 D12.776.467.374.200.110.890 D23.125.300.110.890 D23.469.200.110.890 D23.529.374.200.110.890
|
| Concept/Terms |
Chemokine CCL21- Chemokine CCL21
- CCL21, Chemokine
- 6Ckine
- SLC Chemokine
- Chemokine, SLC
- Exodus-2 Chemokine
- Chemokine, Exodus-2
- Exodus 2 Chemokine
- Secondary Lymphoid-Tissue Chemokine
- Chemokine, Secondary Lymphoid-Tissue
- Lymphoid-Tissue Chemokine, Secondary
- Secondary Lymphoid Tissue Chemokine
- Thymus-Derived Chemotactic Agent 4
- Thymus Derived Chemotactic Agent 4
- CCL21 Chemokine
- Chemokine, CCL21
|
Below are MeSH descriptors whose meaning is more general than "Chemokine CCL21".
Below are MeSH descriptors whose meaning is more specific than "Chemokine CCL21".
This graph shows the total number of publications written about "Chemokine CCL21" by people in this website by year, and whether "Chemokine CCL21" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemokine CCL21" by people in Profiles.
-
Tandon M, Perez P, Burbelo PD, Calkins C, Alevizos I. Laser microdissection coupled with RNA-seq reveal cell-type and disease-specific markers in the salivary gland of Sjögren's syndrome patients. Clin Exp Rheumatol. 2017 Sep-Oct; 35(5):777-785.
-
Gómez D, Diehl MC, Crosby EJ, Weinkopff T, Debes GF. Effector T Cell Egress via Afferent Lymph Modulates Local Tissue Inflammation. J Immunol. 2015 Oct 15; 195(8):3531-6.
-
Novak L, Igoucheva O, Cho S, Alexeev V. Characterization of the CCL21-mediated melanoma-specific immune responses and in situ melanoma eradication. Mol Cancer Ther. 2007 Jun; 6(6):1755-64.
-
Debes GF, Höpken UE, Hamann A. In vivo differentiated cytokine-producing CD4(+) T cells express functional CCR7. J Immunol. 2002 Jun 01; 168(11):5441-7.